Mead Johnson Nutrition (MJN) Q2 2012 Earnings Call July 26, 2012 9:30 am ET Executives Kathy Ann MacDonald - Vice President of Investor Relations and Acting Corporate Controller Stephen W. Golsby - Chief Executive Officer, President and Director Peter Kasper Jakobsen - Chief Operating Officer, Executive Vice President and Director Peter G. Leemputte - Chief Financial Officer and Executive Vice President Analysts Kenneth Goldman - JP Morgan Chase & Co, Research Division Edward Aaron - RBC Capital Markets, LLC, Research Division Matthew C. Grainger - Morgan Stanley, Research Division Eric R. Katzman - Deutsche Bank AG, Research Division Jason English - Goldman Sachs Group Inc., Research Division David Driscoll - Citigroup Inc, Research Division Bryan D. Spillane - BofA Merrill Lynch, Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Mead Johnson Nutrition Second Quarter 2012 Earnings Conference Call. My name is Chanel, and I'll be your coordinator for today. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to Kathy MacDonald, Vice President, Investor Relations. Please proceed, Kathy. Kathy Ann MacDonald Thank you, and good morning. Welcome to Mead Johnson's second quarter conference call. Speaking today will be Steve Golsby, our Chief Financial Officer; Kasper Jakobsen, our Chief Operating Officer and CEO-elect; and Pete Leemputte, our Chief Financial Officer. Before we get started, let me remind everyone that our comments will include forward-looking statements about our future results, including statements about our financial prospects and projections, new product launches and market conditions, that constitute forward-looking statements for purposes of the Safe Harbor Provision under the Private Securities Litigation Reform Act of 1995.